Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03027232 · ClinicalTrials.gov registry record
Control of Leukocyte Function
A clinical trial, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- 100
- Enrollment target
NCT03027232 is a clinical trial that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 100 participants.
The verdict
NCT03027232 has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The protocol is to draw peripheral blood from healthy volunteers for in vitro studies. The aims of these in vitro studies are to determine the cellular and intracellular mechanisms by which hypertonic saline and ATP release regulate neutrophil and lymphocyte functions.
Interventions
- OTHER No intervention (drugs) will be given. Purpose: collecting blood for in vitro studies
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2007-01 |
| Est. Completion | 2017-12-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03027232
The ClinicalTrials.gov registry entry for NCT03027232 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No intervention (drugs) will be given. Purpose: collecting blood for in vitro studies is the first listed.
NCT03027232 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03027232 about?
NCT03027232 is a clinical study titled "Control of Leukocyte Function". The protocol is to draw peripheral blood from healthy volunteers for in vitro studies. The aims of these in vitro studies are to determine the cellular and intracellular mechanisms by which hypertonic saline and ATP release regulate neutrophil and lymphocyte functions.
What is the current status of trial NCT03027232?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2007-01. Estimated completion is 2017-12-15.
What interventions are being tested in trial NCT03027232?
The interventions under investigation include: No intervention (drugs) will be given. Purpose: collecting blood for in vitro studies (OTHER).
Who is sponsoring clinical trial NCT03027232?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.